PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 31.65 CHF 0.32% Market Closed
Market Cap: 1B CHF
Have any thoughts about
PolyPeptide Group AG?
Write Note

Wall Street
Price Targets

PPGN Price Targets Summary
PolyPeptide Group AG

Wall Street analysts forecast PPGN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PPGN is 29.71 CHF with a low forecast of 19.19 CHF and a high forecast of 35.7 CHF.

Lowest
Price Target
19.19 CHF
39% Downside
Average
Price Target
29.71 CHF
6% Downside
Highest
Price Target
35.7 CHF
13% Upside
PolyPeptide Group AG Competitors:
Price Targets
ICLR
ICON PLC
70% Upside
GENO
Genovis AB
47% Upside
4880
CellSource Co Ltd
39% Upside
300347
Hangzhou Tigermed Consulting Co Ltd
3% Downside
IQV
IQVIA Holdings Inc
26% Upside
BICO
BICO Group AB
191% Upside
688222
HitGen Inc
11% Downside
1SXP
SCHOTT Pharma AG & Co KgaA
23% Upside

Revenue
Forecast

Revenue Estimate
PolyPeptide Group AG

For the last 4 years the compound annual growth rate for PolyPeptide Group AG's revenue is 12%. The projected CAGR for the next 3 years is 14%.

12%
Past Growth
14%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
PolyPeptide Group AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
PolyPeptide Group AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PPGN's stock price target?
Price Target
29.71 CHF

According to Wall Street analysts, the average 1-year price target for PPGN is 29.71 CHF with a low forecast of 19.19 CHF and a high forecast of 35.7 CHF.

What is PolyPeptide Group AG's Revenue forecast?
Projected CAGR
14%

For the last 4 years the compound annual growth rate for PolyPeptide Group AG's revenue is 12%. The projected CAGR for the next 3 years is 14%.

Back to Top